Shantha Biologics has announced that it has entered into an outsourcing agreement with Novo Nordisk to provide cartridge fill-finish manufacturing services in India.
MGS, a healthcare contract development and manufacturing organisation (CDMO), has announced the global expansion of its hybrid tooling offering following successful implementation alongside the company’s A.i.r. Platform.
ViCentra has announced that commercial‑scale production of Kaleido consumables, including infusion sets and insulin cartridges, has begun at Phillips Medisize, a Molex company and medtech CDMO.
Hongene Biotech Corporation has announced its support of SiranBio’s SA1211 program, showing how Hongene works across different stages of developing and manufacturing structurally complex oligonucleotide therapeutics.
Vetter, a global Contract Development and Manufacturing Organisation (CDMO), announced progress in the continued expansion of its global clinical manufacturing network.
Ardena, a CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces that its new GLP bioanalytical laboratory in Somerset, New Jersey, is now operational and supporting client studies.
Cartherics Pty, a biotechnology company developing off-the-shelf immune cell therapies for high-impact women’s diseases, including ovarian cancer and endometriosis, and Catalent has announced an enhanced partnership.
Collaboration and innovation in challenging market conditions were among the key outputs from this year’s BCMPA Conference, which was held at the Oxford Belfry.
